Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

Long non-coding RNAs (lncRNAs) are regulators of cellular machinery that are commonly
dysregulated in genitourinary malignancies. Accordingly, the investigation of lncRNAs is …

Objective: This study investigated the effects of lncRNA SNHG1 on the proliferation,
migration, and invasiveness of cervical cancer cells. Methods: Three pairs of cervical cancer …

Background Long noncoding RNAs (lncRNA) contained in exosomes have been recognized
as promising stable biomarkers in cancers. H19 is a well-known oncogenic lncRNA, but …

Early detection of bladder cancer (BC) is essential for improvement of the patient's prognosis
and general survival rates. Current diagnostic methods are still limited, so new specific and …

Background/Aims: MIAT is a long noncoding RNA (lncRNA) involved in cell proliferation and
the development of tumor. However, the exact effects and molecular mechanisms of MIAT in …

The aim of the current study was to investigate the role of enhancer of zeste 2 polycomb
repressive complex 2 subunit (EZH2) in the progression of bladder cancer. Human bladder …

The mortality and morbidity that characterize bladder cancer compel this malignancy into the
category of hot topics in terms of biomolecular research. Therefore, a better knowledge of …

Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …

According to data of the International Agency for Research on Cancer and the World Health
Organization (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health …